Nasopharyngeal carcinoma: Difference between revisions
Line 43: | Line 43: | ||
==Treatment== | ==Treatment== | ||
[[Nasopharyngeal carcinoma medical therapy|Medical therapy]] | [[Nasopharyngeal carcinoma surgery|Surgery]] | [[Nasopharyngeal carcinoma primary prevention|Primary | [[Nasopharyngeal carcinoma medical therapy|Medical therapy]] | [[Nasopharyngeal carcinoma surgery|Surgery]] | [[Nasopharyngeal carcinoma primary prevention|Primary Prevention]] | [[Nasopharyngeal carcinoma secondary prevention|Secondary Prevention]] | [[Nasopharyngeal carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nasopharyngeal carcinoma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 19:43, 11 September 2012
For patient information click here
Nasopharyngeal carcinoma | |
Metastatic nasopharyngeal carcinoma in a lymph node | |
ICD-10 | C11 |
ICD-9 | 147 |
OMIM | 161550 |
DiseasesDB | 8814 |
MedlinePlus | 001042 |
MeSH | D009303 |
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma |
Risk calculators and risk factors for Nasopharyngeal carcinoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Michael Maddaleni, B.S.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nasopharyngeal carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies